About Biocon Biocon's Products & Services Research & Development Biocon's Technology Investors Media Careers CSR
  > INVESTORS
  Overview
  Corporate Structure
  Corporate Governance
  Company History
  Annual General Meeting
  Postal Ballot
  Investor FAQs
  Stock Info
  Financial Results
  Subsidiary Financials
  Annual Report
  Disclosure to Stock Exchange
  Nomination form
  Press Releases
  Presentations
  Analyst Coverage
  Investor Contacts
  
  
     
 
Disclosure to Stock Exchange

  December 2019
26 Dec Intimation for Incorporation of Biocon Biosphere Limited as Wholly Owned Subsidiary of the Company Download Pdf
13 Dec Updated Investor Presentation on "Biocon Biologics - Transforming Healthcare. Transforming Lives" Download Pdf
12 Dec Change in name of Company's Registrar and Share Transfer Agent Download Pdf
12 Dec Meeting conducted with Institutional Investors / Analysts Download Pdf
12 Dec Press Release Download Pdf
11 Dec Investor Presentation on "Biocon Biologics - Transforming Healthcare. Transforming Lives" Download Pdf
11 Dec Meetings conducted with Institutional Investors / Analysts Download Pdf
10 Dec Meetings conducted with Institutional Investors / Analysts Download Pdf
06 Dec Meetings conducted with Institutional Investors / Analysts Download Pdf
05 Dec Meetings conducted with Institutional Investors / Analysts Download Pdf
04 Dec Meetings conducted with Institutional Investors / Analysts Download Pdf
03 Dec Biocon Biologics Takes Forward Its Mission to Unlock Universal Access to Insulins Globally Download Pdf
03 Dec Siddharth Mittal Takes Over as CEO and Joint Managing Director of Biocon Limited Download Pdf
02 Dec Biocon and Mylan Launch Trastuzumab Biosimilar, OgivriTM (trastuzumab-dkst), in the U.S. Download Pdf
  November 2019
28 Nov Meetings conducted with Institutional Investors / Analysts. Download Pdf
27 Nov USFDA Approves Biocon’s sBLA for Pegfilgrastim New Manufacturing Facility Download Pdf
22 Nov Disclosure of Related Party Transactions for the half year ended September 30, 2019 Download Pdf
21 Nov Meetings conducted with Institutional Investors / Analysts. Download Pdf
18 Nov Press Release Download Pdf
12 Nov Press Release Download Pdf
12 Nov Meetings conducted with Institutional Investors / Analyst Download Pdf
05 Nov Meetings conducted with Institutional Investors / Analyst Download Pdf
05 Nov Press Release Download Pdf
  October 2019
31 Oct Meeting conducted with Institutional Investors / Analysts Download Pdf
28 Oct Press Release Download Pdf
23 Oct Outcome of Board Meeting Download Pdf
23 Oct Press Release on Q2 FY20 Financial Results Download Pdf
23 Oct Change in Directorate and Key Managerial Personnel Download Pdf
10 Oct Notice of Board Meeting – Newspaper Advertisement Download Pdf
10 Oct Press Release Download Pdf
03 Oct Intimation of Board Meeting and Trading Window Closure Download Pdf
03 Oct Press Release Download Pdf
01 Oct Meeting conducted with Institutional Investors / Analysts Download Pdf
  September 2019
27 Sep Meeting conducted with Institutional Investors / Analysts Download Pdf
24 Sep Meeting conducted with Institutional Investors / Analysts Download Pdf
24 Sep Public Announcement Download Pdf
20 Sep U.S. FDA Completes Pre-Approval Inspection of Two New Biocon Biologics Facilities in Bengaluru Download Pdf
19 Sep Meeting conducted with Institutional Investors / Analysts Download Pdf
12 Sep Press Release Download Pdf
12 Sep Meetings conducted with Institutional Investors / Analyst Download Pdf
11 Sep Revised Investor Presentation for Quarter ended June 30, 2019 Download Pdf
11 Sep Meetings conducted with Institutional Investors / Analyst Download Pdf
10 Sep Meetings conducted with Institutional Investors / Analyst Download Pdf
09 Sep Investor Presentation for Quarter ended June 30, 2019. Download Pdf
06 Sep Meetings conducted with Institutional Investors / Analysts. Download Pdf
04 Sep Meetings conducted with Institutional Investors / Analysts. Download Pdf
  August 2019
31 Aug Regulation 30 of SEBI Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015 Download Pdf
29 Aug Meeting conducted with Institutional Investors/ Analysts. Download Pdf
27 Aug Meetings conducted with Institutional Investors/ Analysts. Download Pdf
21 Aug Meetings conducted with Institutional Investors/Analysts Download Pdf
3 Aug Meeting conducted with Institutional Investors/ Analysts. Download Pdf
1 Aug Press Release titled Mylan and Biocon Launch First Trastuzumab Biosimilar, Ogivri™, in Australia Download Pdf
  July 2019
31 July Change in Directorate Download Pdf
31 July Meeting conducted with Institutional Investors/Research Analysts Download Pdf
30 July Meeting conducted with Institutional Investors/Research Analysts Download Pdf
27 July Voting Results along with Scrutinizer’s report and Proceeding of 41st AGM Download Pdf
25 July Press Release on Q1 FY20 financial results Download Pdf
25 July Outcome of Board Meeting - Financial Results for the quarter ended June 30, 2019 Download Pdf
25 July Appointment of Mr. Mayank Verma as Company Secretary and Compliance Officer Download Pdf
08 July Pre -Approval U.S. FDA Inspection Conducted at Biocon's lnsulins Facilities in Malaysia Download Pdf
05 July Newspaper advertisement confirming dispatch of Notice of the 41st AGM and the Annual Report for the FY 2018-19. Download Pdf
05 July Notice of Board Meeting – Newspaper Advertisement Download Pdf
05 July Dividend Updates Download Pdf
04 July Intimation of Board Meeting and Trading Window Closure Download Pdf
  June 2019
28 June Meetings conducted with Institutional Investors/Research Analysts. Download Pdf
28 June Notice of 41st Annual General Meeting and the Annual Report for the FY 2018-19 of the Company. Download Pdf
27 June Meetings conducted with Institutional Investors/Research Analysts. Download Pdf
19 June Newspaper Advertisement for transfer of equity shares to IEPF Download Pdf
19 June Meetings conducted with Institutional Investors/Research Analysts Download Pdf
17 June Outcome of the Board meeting Download Pdf
17 June Meetings conducted with Institutional Investors/Research Analysts. Download Pdf
15 June Allotment of Bonus Equity Shares Download Pdf
14 June Biocon Biologics Facilities in Bengaluru Receive EU GMP Certification Download Pdf
14 June Meetings conducted with Institutional Investors/Research Analysts. Download Pdf
13 June Investor Presentation on "Biosimilars- The Next Big Global Healthcare Opportunity Download Pdf
12 June Meetings conducted with Institutional Investors/Research Analysts. Download Pdf
07 June Meetings conducted with Institutional Investors/Research Analysts. Download Pdf
04 June Postal Ballot – Voting Result along with Scrutinizers Report and amended Memorandum of Association Download Pdf
04 June Meetings conducted with Institutional Investors/Research Analysts. Download Pdf
  May 2019
31 May Intimation of Record Date for Issue of Bonus Shares Download Pdf
30 May Meetings conducted with Institutional Investors/Research Analysts. Download Pdf
29 May Meeting conducted with Institutional Investors/Research Analysts. Download Pdf
27 May Investor Presentation for Quarter ended March 31, 2019. Download Pdf
24 May Disclosure of Related Party Transactions pursuant to Regulation 23(9) of SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015 ("SEBI Listing Regulation") Download Pdf
22 May Press Release - Regulation 30 of SEBI Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015. Download Pdf
16 May Press Release - Regulation 30 of SEBI Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015. Download Pdf
16 May Meeting conducted with Institutional Investors/Research Analysts. Download Pdf
10 May Meeting conducted with Institutional Investors/Research Analysts. Download Pdf
09 May Meeting conducted with Institutional Investors/Research Analysts. Download Pdf
07 May Newspaper Advertisement for Notice of Postal Ballot Download Pdf
07 May Meeting conducted with Institutional Investors/Research Analysts. Download Pdf
03 May Postal Ballot Notice under Regulation 30 of SEBI (listing Obligation and Disclosure Requirements), Regulations, 2015 ("SEBI Listing Regulations") Download Pdf
03 May Meetings conducted with Institutional Investors/Research Analysts. Download Pdf
  April 2019
30 Apr Meetings conducted with Institutional Investors/Research Analysts. Download Pdf
25 Apr Outcome of the Board Meeting Download Pdf
22 Apr Intimation for proposal to consider and recommendation of Final Dividend and Bonus issue by the Company Download Pdf
11 Apr Intimation of Board Meeting Download Pdf
02 Apr  Outcome of Board meeting held on April 1,  2019 Download Pdf
  March 2019
29 Mar Meetings conducted with Institutional Investors/Research Analysts. Download Pdf
16 Mar Intimation for change in Compliance Officer Download Pdf
15 Mar Meetings conducted with Institutional Investors/Research Analysts Download Pdf
13 Mar Outcome of Meeting - Postal Ballot Download Pdf
13 Mar Result Announcement Postal Ballot Download Pdf
11 Mar Meeting conducted with Institutional Investors/Research Analysts. Download Pdf
07 Mar Meetings conducted with Institutional Investors/Research Analysts. Download Pdf
06 Mar Meetings conducted with Institutional Investors/Research Analysts. Download Pdf
06 Mar Biocon Facility Completes Pre Approval U.S. FDA Inspection Download Pdf
05 Mar Meetings conducted with Institutional Investors/Research Analysts. Download Pdf
02 Mar Biocon Appoints Dr. Christiane Hamacher as CEO of Biocon Biologics India Limited. Download Pdf
01 Mar Meeting conducted with Institutional Investors/Research Analysts Download Pdf
  February 2019
26 Feb Meetings conducted with Institutional Investors/Research Analysts. Download Pdf
18 Feb Biocon Facilities complete Pre Approval U.S.FDA lnspection Download Pdf
15 Feb Meetings conducted with Institutional Investors / Research Analysts Download Pdf
08 Feb Intimation of Postal Ballot and Cut-off date Download Pdf
04 Feb Cancer Task Force Recommends Guidelines for Cancer Care- Press Release Download Pdf
  January 2019
29 Jan Meetings conducted with Institutional Investors/Research Analysts Download Pdf
25 Jan Press Release for the quarter ended December 31, 2018 Download Pdf
24 Jan Outcome of Board meeting held on January 24, 2019 Download Pdf
24 Jan Unaudited Financial Results (Standalone and Consolidated) for the quarter ended December 31, 2018 Download Pdf
09 Jan Intimation of Board Meeting Download Pdf

 
     
 January 2020
 January to December 2019
 January to December 2018
 January to December 2017
 January to December 2016
 December 2015
 
 
     
  Biocon

Businesses

Recommended sites Biocon on  
  Home
About Us

Investor Relations
Media Relations
Careers
Site Map
Contact Us
Our Growth Accelerators
Fact Sheet
Branded Formulations
Biopharmaceuticals
Research Services
Active Discovery Program

ABLE
Karnataka Vision Group on BT
Syngene International
Biocon Academy

    Linked In   
       
  Report adverse event/side effects and product complaints    
       
  * Disclaimer            © 2018, Biocon. All Rights Reserved